title: Erythrocytosis in a child due to Hb Andrew-Minneapolis [β144(HC1)Lys→Asn (AAG>AAT or AAC)] associated with a Spanish (δβ)(0)-thalassemia.
abstract: We report a rare association of δβ-thalassemia (δβ-thal) and a hemoglobin (Hb) variant with high oxygen affinity in a Spanish newborn. The proband had no Hb A and showed microcytosis and hypochromia; the peripheral blood smear was compatible with a thalassemia trait. Molecular studies revealed that the proband had a Spanish (δβ)(0)-thal (inherited from his father) and also carried a de novo variant (Hb Andrew-Minneapolis) because from the point of hematology, his mother was quite normal.   The hemoglobinopathies with high affinity for oxygen constitute an infrequent cause of secondary congenital erythrocytosis. The degree of erythrocytosis and the resulting clinical manifestations are highly variable, depending on the degree of altered oxygen affinity and the presence of thalassemic genes. Thus, when these variants are associated with β(0)- or δβ-thal, as in our case, the proportion of abnormal Hb is ∼100.0%, which may cause polycythemia, hyperviscosity, and iron deficiency. This type of association is very rare and few have been described, especially in children, as they would normally be detected in adults as the increased packed cell volume (PCV) also increases blood viscosity and causes the typical symptoms (cephalalgia, drowsiness, dizziness).   The association of a high oxygen affinity Hb and a δβ-thal presents a greater degree of erythrocytosis than when this same variant is associated with a β(0)-thal, mainly because the Hb F percentage is usually greater in the δβ-thal, and Hb F normally shows a greater affinity for oxygen and a reduced P(50), although one must always take into account the degree of oxygen affinity of the Hb variant. Familial erythrocytosis and an abnormal electrophoresis finding are indicative of a high affinity Hb. However, the absence of these findings does not reject the possibility of hemoglobinopathies, and in these cases, functional and molecular studies would be justified and should be mandatory for the differential diagnosis of erythrocytosis.
authors.affiliation: Servicio de Hematología, Hospital Clínico San Carlos, Madrid, Spain. propero.hcsc@salud.madrid.org
authors.forename: Paloma
authors.initials: P
authors.lastname: Ropero
authors.forename: Fernando A
authors.initials: FA
authors.lastname: González
authors.forename: Elena
authors.initials: E
authors.lastname: Cela
authors.forename: Cristina
authors.initials: C
authors.lastname: Beléndez
authors.forename: Beatriz
authors.initials: B
authors.lastname: Pérez
authors.forename: Cristina
authors.initials: C
authors.lastname: Seri
authors.forename: Emilia
authors.initials: E
authors.lastname: Fontanes
authors.forename: Ana
authors.initials: A
authors.lastname: Villegas
authors.forename: Joaquin
authors.initials: J
authors.lastname: Díaz-Mediavilla
mesh_terms: D006455:Hemoglobins, Abnormal / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D010100:Oxygen / Q000378:metabolism; D011086:Polycythemia / Q000097:blood / Q000150:complications* / Q000235:genetics; D017086:beta-Thalassemia / Q000097:blood / Q000150:complications* / Q000235:genetics; D055538:delta-Thalassemia / Q000097:blood / Q000150:complications* / Q000235:genetics
chemical_list: D006455:Hemoglobins, Abnormal; C060133:hemoglobin Andrew-Minneapolis; D010100:Oxygen